Global Antihemophilic Factor Market has been getting lots of traction from different emerging countries and regions and in the times of COVID-19, the market is expected to change % in terms of year on year growth. To study the impact of COVID-19, the research has been segmented by Type, By Application, By Regions and By Companies. The report will shed light on very important growth aspect of Antihemophilic Factor and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
Antihemophilic Factor Market Analysis By Type Segment:
Powder
Liquid
Key data provided:
Market Size By Application
Market Share By Application
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Price (If Available)
Antihemophilic Factor Market Analysis By Application Segment:
Hospital
Clinic
Key data provided:
Market Size By Application
Market Share By Application
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Antihemophilic Factor Market Analysis By Regions (Countries):-
The Antihemophilic Factor Market has been thoroughly researched with help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the regions i.e. North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Antihemophilic Factor Report:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Key data provided:
Market Size By Regions and Countries
Market Share By Regions and Countries
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Antihemophilic Factor Market:
Antihemophilic Factor market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The major vendors covered:
Biogen Idec
Bayer
Octapharma
Novo Nordisk
Baxter
Genetics Institute
Wyeth Pharmaceuticals
The study objectives are:
To analyze and research the Antihemophilic Factor Market status and future forecast in North America, Europe, APAC and MEA involving value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antihemophilic Factor Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Available Customizations in The Report:
We can add additional companies as per your choice in the report
We can add specific country/countries of your choice
We can add additional segments such as market by technology, raw material, distribution channel, platform etc.*
Investment Analysis in specific country
We can source details of suppliers and distributors for potential collaboration
* Data is subject to availability
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antihemophilic Factor Market Size Growth Rate by Type (2020-2027)
1.3.2 Powder
1.3.3 Liquid
1.4 Market Segment by Application
1.4.1 Global Antihemophilic Factor Market Share by Application (2020-2027)
1.4.2 Hospital
1.4.3 Clinic
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antihemophilic Factor Market Size
2.1.1 Global Antihemophilic Factor Revenue 2016-2027
2.1.2 Global Antihemophilic Factor Sales 2016-2027
2.2 Antihemophilic Factor Growth Rate by Regions
2.2.1 Global Antihemophilic Factor Sales by Regions 2016-2020
2.2.2 Global Antihemophilic Factor Revenue by Regions 2016-2020
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Antihemophilic Factor Sales by Manufacturers
3.1.1 Antihemophilic Factor Sales by Manufacturers 2016-2020
3.1.2 Antihemophilic Factor Sales Market Share by Manufacturers 2016-2020
3.2 Revenue by Manufacturers
3.2.1 Antihemophilic Factor Revenue by Manufacturers (2016-2020)
3.2.2 Antihemophilic Factor Revenue Share by Manufacturers (2016-2020)
3.2.3 Global Antihemophilic Factor Market Concentration Ratio (CR5 and HHI)
3.3 Antihemophilic Factor Price by Manufacturers
3.4 Key Manufacturers Antihemophilic Factor Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antihemophilic Factor Market
3.6 Key Manufacturers Antihemophilic Factor Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Powder Sales and Revenue (2016-2020)
4.1.2 Liquid Sales and Revenue (2016-2020)
4.2 Global Antihemophilic Factor Sales Market Share by Type
4.3 Global Antihemophilic Factor Revenue Market Share by Type
4.4 Antihemophilic Factor Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Antihemophilic Factor Sales by Application
6 United States
6.1 United States Antihemophilic Factor Breakdown Data by Company
6.2 United States Antihemophilic Factor Breakdown Data by Type
6.3 United States Antihemophilic Factor Breakdown Data by Application
7 European Union
7.1 European Union Antihemophilic Factor Breakdown Data by Company
7.2 European Union Antihemophilic Factor Breakdown Data by Type
7.3 European Union Antihemophilic Factor Breakdown Data by Application
8 China
8.1 China Antihemophilic Factor Breakdown Data by Company
8.2 China Antihemophilic Factor Breakdown Data by Type
8.3 China Antihemophilic Factor Breakdown Data by Application
9 Rest of World
9.1 Rest of World Antihemophilic Factor Breakdown Data by Company
9.2 Rest of World Antihemophilic Factor Breakdown Data by Type
9.3 Rest of World Antihemophilic Factor Breakdown Data by Application
9.4 Rest of World Antihemophilic Factor Breakdown Data by Countries
9.4.1 Rest of World Antihemophilic Factor Sales by Countries
9.4.2 Rest of World Antihemophilic Factor Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Biogen Idec
10.1.1 Biogen Idec Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Antihemophilic Factor
10.1.4 Antihemophilic Factor Product Introduction
10.1.5 Biogen Idec Recent Development
10.2 Bayer
10.2.1 Bayer Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Antihemophilic Factor
10.2.4 Antihemophilic Factor Product Introduction
10.2.5 Bayer Recent Development
10.3 Octapharma
10.3.1 Octapharma Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Antihemophilic Factor
10.3.4 Antihemophilic Factor Product Introduction
10.3.5 Octapharma Recent Development
10.4 Novo Nordisk
10.4.1 Novo Nordisk Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Antihemophilic Factor
10.4.4 Antihemophilic Factor Product Introduction
10.4.5 Novo Nordisk Recent Development
10.5 Baxter
10.5.1 Baxter Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Antihemophilic Factor
10.5.4 Antihemophilic Factor Product Introduction
10.5.5 Baxter Recent Development
10.6 Genetics Institute
10.6.1 Genetics Institute Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Antihemophilic Factor
10.6.4 Antihemophilic Factor Product Introduction
10.6.5 Genetics Institute Recent Development
10.7 Wyeth Pharmaceuticals
10.7.1 Wyeth Pharmaceuticals Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Antihemophilic Factor
10.7.4 Antihemophilic Factor Product Introduction
10.7.5 Wyeth Pharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Antihemophilic Factor Sales Channels
11.2.2 Antihemophilic Factor Distributors
11.3 Antihemophilic Factor Customers
12 Market Forecast
12.1 Global Antihemophilic Factor Sales and Revenue Forecast 2020-2027
12.2 Global Antihemophilic Factor Sales Forecast by Type
12.3 Global Antihemophilic Factor Sales Forecast by Application
12.4 Antihemophilic Factor Forecast by Regions
12.4.1 Global Antihemophilic Factor Sales Forecast by Regions 2020-2027
12.4.2 Global Antihemophilic Factor Revenue Forecast by Regions 2020-2027
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Antihemophilic Factor Product Picture
Table Antihemophilic Factor Key Market Segments
Table Major Manufacturers Antihemophilic Factor Covered in This Report
Table Global Antihemophilic Factor Market Size Growth Rate by Type 2020-2027(K Units) & (Million US$)
Figure Global Antihemophilic Factor Sales Market Shar by Type 2016-2027
Figure Powder Figures
Table Major Manufacturers of Powder
Figure Liquid Figures
Table Major Manufacturers of Liquid
Table Global Antihemophilic Factor Market Share by Application 2020-2027(K Units)
Figure Hospital Use Case
Figure Clinic Use Case
Figure Antihemophilic Factor Report Years Considered
Figure Global Antihemophilic Factor Market Size 2016-2027 (Million US$)
Figure Global Antihemophilic Factor Sales 2016-2020 (K Units)
Table Global Antihemophilic Factor Market Size by Regions 2016-2020 (K Units) & (Million US$)
Table Global Antihemophilic Factor Sales by Regions 2016-2020 (K Units)
Table Global Antihemophilic Factor Sales Market Share by Regions 2016-2020
Figure Global Antihemophilic Factor Sales Market Share by Regions 2016-2020
Figure Global Antihemophilic Factor Sales Market Share by Regions in 2020
Table Global Antihemophilic Factor Revenue by Regions 2016-2020 (Million US$)
Table Global Antihemophilic Factor Revenue Market Share by Regions 2016-2020
Figure Global Antihemophilic Factor Revenue Market Share by Regions 2016-2020
Figure Global Antihemophilic Factor Revenue Market Share by Regions in 2020
Table Market Top Trends
Table Global Antihemophilic Factor Sales by Manufacturers (2016-2020) (K Units)
Table Global Antihemophilic Factor Sales Share by Manufacturers (2016-2020)
Figure Global Antihemophilic Factor Sales Share by Manufacturers in 2020
Table Antihemophilic Factor Revenue by Manufacturers (2016-2020) (Million USD)
Table Antihemophilic Factor Revenue Share by Manufacturers (2016-2020)
Figure Antihemophilic Factor Value Share by Manufacturers in 2020
Table Global Antihemophilic Factor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Antihemophilic Factor Price (2016-2020) (USD/Unit)
Table Key Manufacturers Antihemophilic Factor Plants/Factories Distribution
Table Key Manufacturers Antihemophilic Factor Area Served
Table Date of Key Manufacturers Enter into Antihemophilic Factor Market
Table Key Manufacturers Antihemophilic Factor Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Powder Sales and Revenue (2016-2020) (K Units) & (Million US$)
Table Global Liquid Sales and Revenue (2016-2020) (K Units) & (Million US$)
Table Global Antihemophilic Factor Sales by Type (2016-2020) (K Units)
Table Global Antihemophilic Factor Sales Share by Type (2016-2020)
Figure Global Antihemophilic Factor Sales Market Share by Type (2016-2020)
Figure Global Antihemophilic Factor Sales Market Share by Type in 2020
Table Global Antihemophilic Factor Revenue by Type (2016-2020) (Million US$)
Table Global Antihemophilic Factor Revenue Share by Type (2016-2020)
Figure Global Antihemophilic Factor Revenue Market Share by Type (2016-2020)
Figure Global Antihemophilic Factor Revenue Market Share by Type in 2020
Table Antihemophilic Factor Price by Type 2016-2020 (USD/Unit)
Table Global Antihemophilic Factor Sales by Application (2016-2020) (K Units)
Table Global Antihemophilic Factor Sales Share by Application (2016-2020)
Figure Global Sales Antihemophilic Factor Market Share by Application (2016-2020)
Figure Global Sales Antihemophilic Factor Market Share by Application (2016-2020)
Figure United States Antihemophilic Factor Sales Growth Rate 2016-2020 (K Units)
Figure United States Antihemophilic Factor Revenue Growth Rate 2016-2020 (Million US$)
Table United States Antihemophilic Factor Sales by Company (2016-2020) (K Units)
Table United States Antihemophilic Factor Sales Market Share by Company (2016-2020)
Figure United States Antihemophilic Factor Sales Market Share by Company in 2020
Table United States Antihemophilic Factor Sales by Type (2016-2020) (K Units)
Table United States Antihemophilic Factor Sales Market Share by Type (2016-2020)
Figure United States Antihemophilic Factor Market Share by Type in 2020
Table United States Antihemophilic Factor Sales by Application (2016-2020) (K Units)
Table United States Antihemophilic Factor Sales Market Share by Application (2016-2020)
Figure United States Antihemophilic Factor Market Share by Application in 2020
Figure European Union Antihemophilic Factor Sales Growth Rate 2016-2020 (K Units)
Figure European Union Antihemophilic Factor Revenue Growth Rate 2016-2020 (Million US$)
Table European Union Antihemophilic Factor Sales by Company (2016-2020) (K Units)
Table European Union Antihemophilic Factor Sales Market Share by Company (2016-2020)
Figure European Union Antihemophilic Factor Sales Market Share by Company in 2020
Table European Union Antihemophilic Factor Sales by Type (2016-2020) (K Units)
Table European Union Antihemophilic Factor Sales Market Share by Type (2016-2020)
Figure 2020 European Union Antihemophilic Factor Market Share by Type
Table European Union Antihemophilic Factor Sales by Application (2016-2020) (K Units)
Table European Union Antihemophilic Factor Sales Market Share by Application (2016-2020)
Figure 2020 European Union Antihemophilic Factor Market Share by Application
Figure China Antihemophilic Factor Sales Growth Rate 2016-2020 (K Units)
Figure China Antihemophilic Factor Revenue Growth Rate 2016-2020 (Million US$)
Table China Antihemophilic Factor Sales by Company (2016-2020) (K Units)
Table China Antihemophilic Factor Sales Market Share by Company (2016-2020)
Figure China Antihemophilic Factor Sales Market Share by Company in 2020
Table China Antihemophilic Factor Sales by Type (2016-2020) (K Units)
Table China Antihemophilic Factor Sales Market Share by Type (2016-2020)
Figure China Antihemophilic Factor Market Share by Type in 2020
Table China Antihemophilic Factor Sales by Application (2016-2020) (K Units)
Table China Antihemophilic Factor Sales Market Share by Application (2016-2020)
Figure China Antihemophilic Factor Market Share by Application in 2020
Figure Rest of World Antihemophilic Factor Sales Growth Rate 2016-2020 (K Units)
Figure Rest of World Antihemophilic Factor Revenue Growth Rate 2016-2020 (Million US$)
Table Rest of World Antihemophilic Factor Sales by Company (2016-2020) (K Units)
Table Rest of World Antihemophilic Factor Sales Market Share by Company (2016-2020)
Figure Rest of World Antihemophilic Factor Sales Market Share by Company in 2020
Table Rest of World Antihemophilic Factor Sales by Type (2016-2020) (K Units)
Table Rest of World Antihemophilic Factor Sales Market Share by Type (2016-2020)
Figure Rest of World Antihemophilic Factor Market Share by Type in 2020
Table Rest of World Antihemophilic Factor Sales by Application (2016-2020) (K Units)
Table Rest of World Antihemophilic Factor Sales Market Share by Application (2016-2020)
Figure Rest of World Antihemophilic Factor Market Share by Application in 2020
Table Rest of World Antihemophilic Factor Sales by Countries (2016-2020) (K Units)
Table Rest of World Antihemophilic Factor Sales Market Share by Countries (2016-2020)
Figure Rest of World Antihemophilic Factor Sales Market Share by Countries in 2020
Table Rest of World Antihemophilic Factor Revenue by Countries (2016-2020) (Million US$)
Table Rest of World Antihemophilic Factor Revenue Market Share by Countries (2016-2020)
Figure Rest of World Antihemophilic Factor Revenue Market Share by Countries in 2020
Figure Japan Antihemophilic Factor Sales Growth Rate (2016-2020) (K Units)
Figure Japan Antihemophilic Factor Revenue Growth Rate (2016-2020) (K Units)
Figure Korea Antihemophilic Factor Sales Growth Rate (2016-2020) (K Units)
Figure Korea Antihemophilic Factor Revenue Growth Rate (2016-2020) (K Units)
Figure India Antihemophilic Factor Sales Growth Rate (2016-2020) (K Units)
Figure India Antihemophilic Factor Revenue Growth Rate (2016-2020) (K Units)
Figure Southeast Asia Antihemophilic Factor Sales Growth Rate (2016-2020) (K Units)
Figure Southeast Asia Antihemophilic Factor Revenue Growth Rate (2016-2020) (K Units)
Table Biogen Idec Company Details
Table Biogen Idec Description and Business Overview
Table Biogen Idec Antihemophilic Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Biogen Idec Antihemophilic Factor Sales Growth Rate (2016-2020)
Table Biogen Idec Antihemophilic Factor Sales Market Share in Global Market
Table Biogen Idec Recent Development
Table Bayer Company Details
Table Bayer Description and Business Overview
Table Bayer Antihemophilic Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Bayer Antihemophilic Factor Sales Growth Rate (2016-2020)
Table Bayer Antihemophilic Factor Sales Market Share in Global Market
Table Bayer Recent Development
Table Octapharma Company Details
Table Octapharma Description and Business Overview
Table Octapharma Antihemophilic Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Octapharma Antihemophilic Factor Sales Growth Rate (2016-2020)
Table Octapharma Antihemophilic Factor Sales Market Share in Global Market
Table Octapharma Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Description and Business Overview
Table Novo Nordisk Antihemophilic Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Novo Nordisk Antihemophilic Factor Sales Growth Rate (2016-2020)
Table Novo Nordisk Antihemophilic Factor Sales Market Share in Global Market
Table Novo Nordisk Recent Development
Table Baxter Company Details
Table Baxter Description and Business Overview
Table Baxter Antihemophilic Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Baxter Antihemophilic Factor Sales Growth Rate (2016-2020)
Table Baxter Antihemophilic Factor Sales Market Share in Global Market
Table Baxter Recent Development
Table Genetics Institute Company Details
Table Genetics Institute Description and Business Overview
Table Genetics Institute Antihemophilic Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Genetics Institute Antihemophilic Factor Sales Growth Rate (2016-2020)
Table Genetics Institute Antihemophilic Factor Sales Market Share in Global Market
Table Genetics Institute Recent Development
Table Wyeth Pharmaceuticals Company Details
Table Wyeth Pharmaceuticals Description and Business Overview
Table Wyeth Pharmaceuticals Antihemophilic Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Wyeth Pharmaceuticals Antihemophilic Factor Sales Growth Rate (2016-2020)
Table Wyeth Pharmaceuticals Antihemophilic Factor Sales Market Share in Global Market
Table Wyeth Pharmaceuticals Recent Development
Figure Antihemophilic Factor Value Chain
Table Antihemophilic Factor Distributors List
Table Antihemophilic Factor Customers List
Table Global Antihemophilic Factor Sales Forecast 2020-2027(K Units) & (Million US$)
Figure Global Antihemophilic Factor Sales Forecast 2020-2027(K Units)
Figure Global Antihemophilic Factor Revenue Forecast 2020-2027(Million US$)
Table Global Antihemophilic Factor Sales Forecast by Type 2020-2027(K Units)
Figure Global Antihemophilic Factor Sales Forecast by Type 2020-2027(K Units)
Figure Global Antihemophilic Factor Sales Market Share Forecast by Type 2020-2025
Table Global Antihemophilic Factor Sales Forecast by Application 2020-2027(K Units)
Figure Global Antihemophilic Factor Sales Forecast by Application 2020-2027(K Units)
Figure Global Antihemophilic Factor Sales Market Share Forecast by Application 2020-2025
Table Global Antihemophilic Factor Sales Forecast by Regions 2020-2027(K Units)
Figure Global Antihemophilic Factor Sales Forecast by Regions 2020-2027(K Units)
Figure Global Antihemophilic Factor Sales Market Share Forecast by Regions 2020-2025
Table Global Antihemophilic Factor Revenue Forecast by Regions 2020-2027(K Units)
Figure Global Antihemophilic Factor Revenue Forecast by Regions 2020-2027(K Units)
Figure Global Antihemophilic Factor Revenue Market Share Forecast by Regions 2020-2025
Figure United States Antihemophilic Factor Sales Forecast 2020-2027(K Units)
Figure United States Antihemophilic Factor Revenue Forecast 2020-2027(Million US$)
Figure European Union Antihemophilic Factor Sales Forecast 2020-2027(K Units)
Figure European Union Antihemophilic Factor Revenue Forecast 2020-2027(Million US$)
Figure China Antihemophilic Factor Sales Forecast 2020-2027(K Units)
Figure China Antihemophilic Factor Revenue Forecast 2020-2027(Million US$)
Figure Japan Antihemophilic Factor Sales Forecast 2020-2027(K Units)
Figure Japan Antihemophilic Factor Revenue Forecast 2020-2027(Million US$)
Figure Korea Antihemophilic Factor Sales Forecast 2020-2027(K Units)
Figure Korea Antihemophilic Factor Revenue Forecast 2020-2027(Million US$)
Figure India Antihemophilic Factor Sales Forecast 2020-2027(K Units)
Figure India Antihemophilic Factor Revenue Forecast 2020-2027(Million US$)
Figure Southeast Asia Antihemophilic Factor Sales Forecast 2020-2027(K Units)
Figure Southeast Asia Antihemophilic Factor Revenue Forecast 2020-2027(Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources